CELULLAR DRUGS TRANSPORTERS. THE JOURNEY OF THE ORAL ANTIDIABETICS AGENTS TROUGH THE ORGANISM
Type 2 diabetes mellitus requires multiple pharmacological treatment in order to achieve therapeutic goals and control comorbidities. Therefore, treatment leads to drug interaction. It means that the observed effects, whether therapeutic or adverse, are the result of the concomitant administration o...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Sello Editorial Lugones
2018-03-01
|
Series: | Revista de la Sociedad Argentina de Diabetes |
Subjects: | |
Online Access: | https://www.revistasad.com/index.php/diabetes/article/view/40 |